Livzon Pharmaceutical Group (Livzon Pharmaceutical Group) Cyclically Adjusted PS Ratio : 3.40 (As of Jun. 20, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Livzon Pharmaceutical Group Cyclically Adjusted PS Ratio?

As of today (2024-06-20), Livzon Pharmaceutical Group's current share price is $3.20. Livzon Pharmaceutical Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.94. Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio for today is 3.40.

The historical rank and industry rank for Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio or its related term are showing as below:

LVZPF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.89 Med: 4.53 Max: 8.31
Current: 3.56

During the past years, Livzon Pharmaceutical Group's highest Cyclically Adjusted PS Ratio was 8.31. The lowest was 2.89. And the median was 4.53.

LVZPF's Cyclically Adjusted PS Ratio is ranked worse than
71.33% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs LVZPF: 3.56

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Livzon Pharmaceutical Group's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.482. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.94 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation

Livzon Pharmaceutical Group Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Cyclically Adjusted PS Ratio Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cyclically Adjusted PS Ratio

Get a 7-Day Free Trial

4.45

4.88

4.35

3.18

3.23

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cyclically Adjusted PS Ratio	Get a 7-Day Free Trial															3.59	3.68	3.42	3.23	3.30

Competitive Comparison of Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio falls into.

Livzon Pharmaceutical Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio	=	Share Price	/	Cyclically Adjusted Revenue per Share
	=	3.20	/	0.94
	=	3.40

Livzon Pharmaceutical Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Livzon Pharmaceutical Group's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare	=	Revenue per Share	/	CPI of Mar. 2024 (Change)	*	Current CPI (Mar. 2024)
	=	0.482	/	115.2271	*	115.2271
	=	0.482

Current CPI (Mar. 2024) = 115.2271.

Livzon Pharmaceutical Group Quarterly Data

	Revenue per Share	CPI	Adj_RevenuePerShare
201406	0.267	98.200	0.313
201409	0.284	98.900	0.331
201412	0.272	99.000	0.317
201503	0.298	99.900	0.344
201506	0.291	99.500	0.337
201509	0.319	100.500	0.366
201512	0.317	100.600	0.363
201603	0.313	102.200	0.353
201606	0.349	101.400	0.397
201609	0.343	102.400	0.386
201612	0.298	102.600	0.335
201703	0.332	103.200	0.371
201706	0.329	103.100	0.368
201709	0.367	104.100	0.406
201712	0.328	104.500	0.362
201803	0.399	105.300	0.437
201806	0.365	104.900	0.401
201809	0.357	106.600	0.386
201812	0.312	106.500	0.338
201903	0.415	107.700	0.444
201906	0.361	107.700	0.386
201909	0.352	109.800	0.369
201912	0.317	111.200	0.328
202003	0.384	112.300	0.394
202006	0.385	110.400	0.402
202009	0.439	111.700	0.453
202012	0.421	111.500	0.435
202103	0.545	112.662	0.557
202106	0.480	111.769	0.495
202109	0.512	112.215	0.526
202112	0.457	113.108	0.466
202203	0.585	114.335	0.590
202206	0.454	114.558	0.457
202209	0.482	115.339	0.482
202212	0.481	115.116	0.481
202303	0.528	115.116	0.529
202306	0.497	114.558	0.500
202309	0.435	115.339	0.435
202312	0.419	114.781	0.421
202403	0.482	115.227	0.482

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Livzon Pharmaceutical Group (OTCPK:LVZPF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

Livzon Pharmaceutical Group Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group (Livzon Pharmaceutical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (OTCPK:LVZPF) » Definitions » Cyclically Adjusted PS Ratio

Traded in Other Exchanges

01513:Hong Kong 000513:China

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (Livzon Pharmaceutical Group) Headlines

No Headlines